Caricamento...
Treatment of Myelofibrosis: Old and New Strategies
Myelofibrosis (MF) is a BCR-ABL1–negative myeloproliferative neoplasm that is mainly characterised by reactive bone marrow fibrosis, extramedullary haematopoiesis, anaemia, hepatosplenomegaly, constitutional symptoms, leukaemic progression, and shortened survival. As such, this malignancy is still o...
Salvato in:
| Pubblicato in: | Clin Med Insights Blood Disord |
|---|---|
| Autori principali: | , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
SAGE Publications
2017
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5428134/ https://ncbi.nlm.nih.gov/pubmed/28579852 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1179545X17695233 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|